| PRODUCTSSERVICESCOMPANYCONTACTFAQ |
|
NSC 612567
1
relevant articles (0 outcomes,
0 trials/studies)
found for this Bio-Agent
Description: structure given in first source
Also Known As:NSC-612567; perhydrothiazinylethyl N-mustard phosphoramide ester; 2H-1,3-Thiazine-4-carboxylic acid, 2-(2-((amino(bis(2-chloroethyl)amino)phosphinyl)oxy)ethyl)tetrahydro-
Bio-Agent Context: Research Results
Related Diseases
| 1. | Lymphoma (Lymphomas)
01/01/1997
- "Repeated applications of 4% LD50 of NSC 613060 and 13% LD50 of NSC 612567 prevented tumour growth in mice with advanced, P388 lymphomas, implanted subcutaneously, without signs of overall toxicity to the host."
Get all the results and reference details, order at left... |
| 1 Diseases and 1 more articles analyzed in the Research Interface, order at left... | |
Related Drugs and Biologics
| 1. | NSC 613060
|
| 1 Drugs and Important Bio-Agents and 1 more articles analyzed in the Research Interface, order at left... | |
Research Interface
- Unlimited Disease, Drug and Therapy Search
- 2 clicks from Disease to Drug to Evidence
- Trial References
- All the Positive Outcomes
- Detailed Relationship Timeline Charts
- Full Article Reference Details
- Includes Mobile Interface Subscription
- One-click to FDA Products/Patents
- Request Institution License details >>
| Price: | $490.00 access via web interface, 1 year subscription |
Mobile Interface
- Access from any web enabled PDA or Phone
- Trial references
- All the Positive Outcomes
- Drug and Therapy searches
- Full Article Reference Details
- Try Mobile Interface >>
| Price: | $45.00 access via "curehunter.com/m", 1 year subscription |